The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Hyperphosphatemia is a common problem in hemodialysis (HD) patients. Different chelators for
control of Hyperphosphatemia are used. The aim of this study was to assess the effect of
magnesium oxide (Mg Oxide) on the control of serum phosphorus (P) level and evaluation of its
side effects in hemodialysis patients.